44 related articles for article (PubMed ID: 10832437)
1. [Current aspects of chemotherapy of metastatic pancreatic and biliary tract carcinomas].
Bokemeyer C; Kollmannsberger C; Oettle H; Kanz L
Praxis (Bern 1994); 2000 Sep; 89(39):1545-52. PubMed ID: 11068508
[TBL] [Abstract][Full Text] [Related]
2. A review of systemic therapy for advanced pancreatic cancer.
El-Rayes BF; Philip PA
Clin Adv Hematol Oncol; 2003 Jul; 1(7):430-4. PubMed ID: 16258429
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of antitumor effect of chemotherapy for pancreatic cancer].
Okada S
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2031-5. PubMed ID: 9388510
[TBL] [Abstract][Full Text] [Related]
4. Regional chemotherapy for advanced pancreatic carcinoma.
Bayar S; Unal E; Tez M; Kocaoglu H; Demirci S; Akgul H
Hepatogastroenterology; 2003; 50(50):550-2. PubMed ID: 12749270
[TBL] [Abstract][Full Text] [Related]
5. Sequential and/or concurrent hypofractionated radiotherapy and concurrent chemotherapy in neoadjuvant treatment of advanced adenocarcinoma of the pancreas. Outcome and patterns of failure.
Zimmermann FB; Schuhmacher C; Lersch C; Bernhardt B; Pickel P; Siewert JR; Molls M; Jeremic B
Hepatogastroenterology; 2004; 51(60):1842-6. PubMed ID: 15532839
[TBL] [Abstract][Full Text] [Related]
6. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
7. Use of cell therapy as a means of targeting chemotherapy to inoperable pancreatic cancer.
Günzburg WH; Salmons B
Acta Biochim Pol; 2005; 52(3):601-7. PubMed ID: 16175235
[TBL] [Abstract][Full Text] [Related]
8. Clinical response to systemic combined chemotherapy with 5-fluorouracil and cisplatin (FP therapy) in patients with advanced pancreatic cancer.
Okusaka T; Okada S; Ishii H; Nose H; Nakasuka H; Nakayama H; Nagahama H
Jpn J Clin Oncol; 1996 Aug; 26(4):215-20. PubMed ID: 8765178
[TBL] [Abstract][Full Text] [Related]
9. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
10. A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma.
Rothenberg ML; Abbruzzese JL; Moore M; Portenoy RK; Robertson JM; Wanebo HJ
Cancer; 1996 Aug; 78(3 Suppl):627-32. PubMed ID: 8681301
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of clinical benefit of chemotherapy in patients with upper gastrointestinal cancer.
Hoffman K; Glimelius B
Acta Oncol; 1998; 37(7-8):651-9. PubMed ID: 10050982
[TBL] [Abstract][Full Text] [Related]
12. Importance of performance status for treatment outcome in advanced pancreatic cancer.
Boeck S; Hinke A; Wilkowski R; Heinemann V
World J Gastroenterol; 2007 Jan; 13(2):224-7. PubMed ID: 17226900
[TBL] [Abstract][Full Text] [Related]
13. Outcomes when cancer treatment is delivered on, or off, a clinical trial: implications for generalizability of study results.
Markman M
Oncology; 2011; 81(3-4):141-2. PubMed ID: 22024941
[No Abstract] [Full Text] [Related]
14. Re: Generalizability of trial results to elderly medicare patients with advanced solid tumors.
Mol L; Koopman M; Ottevanger PB; Punt CJ
J Natl Cancer Inst; 2015 Jun; 107(6):djv104. PubMed ID: 25952033
[No Abstract] [Full Text] [Related]
15. Pain in pancreatic cancer: a medical oncologist's view.
Horton J
J Pain Symptom Manage; 1988; 3(4):168-70. PubMed ID: 3192961
[No Abstract] [Full Text] [Related]
16. Some problems of measurement in clinical trials of physiotherapy, with particular reference to the assessment of pain.
Troup JD
Physiotherapy; 1970 Nov; 56(11):491-6. PubMed ID: 4924036
[No Abstract] [Full Text] [Related]
17. How should pain be controlled in clinical trials for pancreatic cancer?
Sasako M
Jpn J Clin Oncol; 1996 Oct; 26(5):391. PubMed ID: 8895683
[No Abstract] [Full Text] [Related]
18. Pancreatic cancer pain: presentation, pathogenesis and management.
J Pain Symptom Manage; 1988; 3(4):163-209. PubMed ID: 3192960
[No Abstract] [Full Text] [Related]
19. [Evaluation of therapeutic effect of chemotherapy with reference to clinical benefit response].
Okada S
Gan To Kagaku Ryoho; 2000 May; 27(5):696-701. PubMed ID: 10832437
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
